Free Access
J Extra Corpor Technol
Volume 46, Number 1, March 2014
Page(s) 77 - 83
Published online 15 March 2014
  1. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91:944–982. [CrossRef] [Google Scholar]
  2. Menkis AH, Martin J, Cheng DCH, et al. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: A consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2012;7:229–241. [CrossRef] [PubMed] [Google Scholar]
  3. Rosengart TK, DeBois W, O’Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: A safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115:426–439. [CrossRef] [Google Scholar]
  4. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283–290. [CrossRef] [Google Scholar]
  5. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: A meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003;54:207–215. [Google Scholar]
  6. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223–230. [CrossRef] [Google Scholar]
  7. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18:429–437. [CrossRef] [Google Scholar]
  8. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527–533; discussion 534. [CrossRef] [Google Scholar]
  9. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–1911. [CrossRef] [PubMed] [Google Scholar]
  10. Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–745. [CrossRef] [PubMed] [Google Scholar]
  11. Pierson DJ. Complications associated with mechanical ventilation. Crit Care Clin. 1990;6:711–724. [CrossRef] [Google Scholar]
  12. Carson J, Spence R, Poses R, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet. 1988;331:727–729. [CrossRef] [Google Scholar]
  13. Dial S, Delabays E, Albert M, et al. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg. 2005;130:654–661. [Google Scholar]
  14. Roth-Isigkeit A. Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-), IL-1, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery, with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol. 1999;118:242–246. [Google Scholar]
  15. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients [Update of Cochrane Database Syst Rev. 2012;6:CD000567; PMID: 22696320]. Cochrane Database Syst Rev. 2013;2:CD000567. [Google Scholar]
  16. Chelemer SB, Prato BS, Cox PMJr, O’Connor GT, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg. 2002;73:138–142. [CrossRef] [Google Scholar]
  17. Engoren MC, Habib RH, Zacharias A, et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180–1186. [CrossRef] [Google Scholar]
  18. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116:1233–1239. [CrossRef] [PubMed] [Google Scholar]
  19. Habib RH, Zacharias A, Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med. 2005;33:1749–1756. [CrossRef] [PubMed] [Google Scholar]
  20. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119:1461–1468. [CrossRef] [PubMed] [Google Scholar]
  21. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest. 1999;115:1598–1603. [CrossRef] [PubMed] [Google Scholar]
  22. Vamvakas EC, Carven JH. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: The effects of confounding factors. Transfus (Paris). 2000;40:832–839. [CrossRef] [PubMed] [Google Scholar]
  23. Ali MA, Saleh M. Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion. 2004;19:41–45. [CrossRef] [PubMed] [Google Scholar]
  24. Fisher AR, Jones P, Barlow P, et al. The influence of mannitol on renal function during and after open-heart surgery. Perfusion. 1998;13:181–186. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.